Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

MCC Update 08-20-13

AHCMCC2 - Image - 560x80 - Update banner

Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, sherm019@umn.edu, by noon on Friday for publication the following Tuesday.

NOTE: Update will be published bi-weekly until September 10, 2013.

 

August 20, 2013

 

In This Issue

 

News

Clinical Trials

Professional Education

Events

Funding Opportunities


News

Members in the news

Lester Drewes, Ph.D., Masonic Cancer Center member, was quoted in Scientific American story “Breaking the Brain Barrier.” Read more.

Anne Joseph, M.D., co-leader of the Prevention and Etiology Program, was quoted in a story in the Charlotte Observer about e-cigarettes.

August 30 deadline to register for 4th Annual Masonic Cancer Center Research Symposium
The August 30 deadline to register for the poster sessions at the Fourth Annual Research Symposium to be held October 16, 2013 in the Great Hall of Coffman Memorial Union from 10:30 a.m. to 3:30 p.m. is fast approaching.
Register online.

The symposium will include a presentation by Douglas Yee, M.D., Director of the Masonic Cancer Center, two poster sessions, and a keynote speaker. the B.J. Kennedy Lecturer in Medical Oncology Carl June, M.D., Richard W. Vague Professor in Immunotherapy, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania.

Students, staff, postdocs and PIs are encouraged to participate and submit an abstract for the poster session. The poster format is changing this year. Visit the website for more information. A subcommittee will select the best abstract from each research program area for a special opportunity to have lunch with our keynote speaker.

Kudos

Congratulations to Subree Subramanian, Ph.D., Genetic Mechanisms of Cancer Program on receiving an American Cancer Society Research Scholar grant in the amount of $720,000 for 4 years. The title of his project is “MicroRNA gene regulatory networks in the pathogenesis of osteosarcoma.”

Kudos to Selwyn Vickers, M.D., Tumor Microenvironment Program and associate director of Translational Research, who will be honored on Tuesday, October 22, 2013 at the ninth annual Medical Staff Awards dinner for his outstanding work as a clinical scholar and researcher.

Congratulations and a big thank you to Hinda Litman, who was honored recently for graciously volunteering her time to serve cancer patients at the Masonic Cancer Clinic and Breast Center for thirty-four years.

ACS IRG Committee announces research project awards, next application deadline
Masonic Cancer Center's American Cancer Society Institutional Research Grant (ACS IRG) Committee has completed its review of the applications received from the past submission deadline and awarded the following two research projects:

Julie Ostrander, Ph.D., Cell Signaling Program, “PELP1 protein interactions that promote early mammary carcinogenesis”
William Pomerantz, PhD, Carcinogenesis and Chemopreventon Program, “Polarity switching peptides for CREB:KIX inhibition”

The ACS IRG award is $30,000 in direct costs to support the initiation of promising cancer-related research projects by assistant professors. The next application deadline is Monday, October 28, 2013. Instructions and application forms are available by contacting Aaron Schilz schil226@umn.edu or phone: 612-624-0650.

New Resource: VisualDx
The Bio-Medical Library now has access to VisualDx a clinical decision support system that assists health care providers recognize and diagnose visually presenting conditions. VisualDx contains more than 1,200 conditions, represented in over 25,000 images, and has images showing variations in disease presentation by age, skin type, location, and severity. It includes clincial scenarios in pediatric and adult skin conditions, drug eruptions, oral mucosa, pulmonary infections, and many more. This unique resource is available through the Bio-Medical Library’s website and also includes access to a mobile app for Apple and Android devices. Directions for access the mobile app are available here: http://hsl.lib.umn.edu/biomed/help/mobile.

Back to top

Clinical Trials

The following clinical trials conducted by Masonic Cancer Center members were recently opened:

2013CG034
COG ANBL12P1: Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma
PI: Greengard, Emily

2013LS005
MT2013-10: A single-arm, open-label, proof-of-concept study to evaluate the safety and tolerability of infusing HSC835
in patients with hematological malignancies using a non-myeloablative conditioning regimen
PI: Wagner, John

For more information on clinical trials contact Marva Bohen, R.N., B.S.N. (ccinfo@umn.edu,  612-624-2620).

Back to top

Professional Education

September 3, 2013: Program in Health Disparities Research Monthly Meeting
1-2 p.m., Room 105, 717 Delaware
Kola Okuyemi, M.D., Ph.D., Director, Program in Health Disparities Research, Director, Minnesota Center for Cancer Collaborations (MC3), Professor, Department of Family Medicine and Community Health

A light lunch will be served at 12:50 p.m. RSVP to phdr@umn.edu.

September 16, 2013: 10th Annual Women’s Health Research Conference – “Optimizing Women’s Health Through a Life Course Approach”
McNamara Alumni Center, 200 Oak St, Minneapolis, Minn.
Keynote Speakers:
Paula Braveman, M.D., M.P.H., Professor, Family and Community Medicine, University of California-San Francisco
Janet Rich-Edwards, ScD, M.P.H., Investigator, Nurses’ Health Study, Harvard School of Public Health

To register visit the website.

September 26-27, 2013: The Second Minnesota Neuro-Oncology Symposium: Basic Discovery Accelerating Groundbreaking Brain Tumor Therapy
McNamara Alumni Center, 200 Oak Street SE, Minneapolis, Minn.
Presented by: The Brain Tumor Program, Masonic Cancer Center, University of Minnesota, University of Minnesota Medical Center, Fairview, University of Minnesota Amplatz Children’s Hospital

Last day to register is September 6. For more information and to register visit the website.

September 30, 2013: Save the date: Cancer Care Physician Dinner and Workshop
5:30-8 p.m.
Details to follow in August.

Visit the Education and Training Opportunities web page for more conference and special lecture listings.

Back to top

Events 

September 7, 2013: HOM Silent No More Walk/Run for Ovarian Cancer
Rosland Park, Edina

September 15, 2013: Pancreatic Cancer Action Network PurpleRide
8 a.m., Elm Creek Regional Park, 12400 James Deane Parkway, Maple Grove, Minn. 55369
Please join us in the fight against Pancreatic Cancer! The University of Minnesota Team "U" Can Make Difference will be riding on Sunday September 15th, 2013 for the Annual PurpleRide event sponsored by the Pancreatic Cancer Action Network. This is a fun-filled family event and will consist of an 8 and 25 mile bike ride with all proceeds going toward the Pancreatic Cancer Action Network for pancreatic cancer research. Joining our team is easy! If interested please visit the website at www.purpleride.org and click on team: "U" Can Make a Difference." Can't make it that day and/or want more information? Donate online or buy one of our t-shirts to show your support by contacting Sheila Bohnsack at sbohnsac@umn.edu or 612-625-7936. Hope to see you there!

September 18, 2013: Varsity Team Rally
6-9 p.m., Cancer and Cardiovascular Research Building, U of M Biomedical District
Drive cancer research down the field at this unique, insider’s special event.  Help us raise $100,000 for high-priority cancer research projects at Masonic Cancer Center, University of Minnesota. 

For more information and to register, visit www.drivecancerresearch.org.

Visit the Community Events and Outreach page for more information.

Back to top

Funding Opportunities

Notice of Intent to Publish a Funding Opportunity Announcement for "Cancer Detection, Diagnostic and Treatment Technologies for Global Health (UH2/UH3)
(NOT-CA-13-015)
National Cancer Institute
FOA is expected to be published in Fall 2013 with an application deadline in Winter 2014.
This FOA will solicit applications for the development of new technologies/devices and/or adaptation of existing technologies/devices for cancer detection/diagnosis and treatment to be tested and ultimately implemented in low- and middle-income countries (LMICs), as listed by World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups).

Funding Opportunities
                                             
Bridge Grant Program
American Society of Hematology
Application” August 1-November 1, 2013
Funding: $100,000
In 2013 and for the next two years, ASH’s new bridge grant program will provide at least 30 one-year awards annually, in the amount of $100,000 each, to ASH members who applied for an NIH R01 grant or equivalent but were denied funding due to budget cutbacks. The long-term goal of the award is to help sustain recipients’ research and contribute to their retention in hematology investigation.

Career Development Award (CDA) & Young Investigator Award (YIA)
Conquer Cancer Foundation
Application Receipt Date(s): September 26, 2013
Funding: Career Development - $200,000 over 3 years; Young Investigator - $50,000 for one year

Career Catalyst Research Grant
Susan G. Komen Foundation
Application Receipt Dates: Preapplication – September 5, 2013; Full Application – December 5, 2013
Funding: $450,000 combined direct and indirect costs; ($150,000 per year for up to 3 years)

Postdoctoral Fellowship Grant
Susan G. Komen Foundation
Application Receipt Dates: Preapplication – September 5, 2013; Full Application – December 5, 2013
Up to $180,000 direct costs only; ($60,000 per year for 2 to 3 years)

Administrative Supplements to Promote Collaborative Research on Addiction at NIH (CRAN): Comorbidity-Related Research (Admin Supp)
(PA-13-275)
National Cancer Institute
Application Receipt Date(s): September 24, 2013
Funding: Within the approved project period of the parent grant, $100,000 direct costs per year, for up to 2 years.

Advanced Development of Informatics Technology (U24)
(PAR-13-294)
National Cancer Institute
Application Receipt Date(s): November 18, 2013; June 18, 2014; 2 additional
Funding: Up to $500,000 direct costs/year for up to 5 years

Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.

Back to top

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on September 6, 2013